Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.

Kathrin JahreisAlina BrügeSaskia BorsdorfFranziska E MüllerWeilun SunShaobo JiaDong Min KangNicolette BoesenSeulgi ShinSungsu LimAnastasia KorolevaGrzegorz SatałaAndrzej J BojarskiElena RakušaAnne FinkGabriele Doblhammer-ReiterYun Kyung KimAlexander Dityatev Evgeni G PonimaskinJosephine Labus

Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)

Amisulpride may be a disease-modifying drug for tauopathies.

Keyphrases

drug induced
adverse drug
risk assessment
human health
electronic health record